Smoller, David, PhD

CSO, Sigma Life Science


Mr. David A. Smoller, "Dave," has been Chief Scientific Officer of Sigma-Aldrich Corporation since February 2011. Dr. Smoller served as the President of Research Biotech Business Unit of Sigma-Aldrich Corp. since July 5, 2007 and served as its Vice President of Research and Development since June 1, 2004. Dr. Smoller served as President and Chief Executive Officer of ProteoPlex, a seed stage spinout focusing on functional genomics. Dr. Smoller founded ProteoPlex in 2001 and led the St. Louis-based company through its product development and final acquisition. In 1992, Dr. Smoller founded Genome Systems Inc., in St. Louis, which provided the scientific community with access to genome project-related technologies. Dr. Smoller stayed at the helm of Sigma-aldrich Corp. until it was acquired in 1996 by the Incyte Corporation, based in Palo Alto, California. Dr. Smoller joined Incyte as Vice President eventually becoming Senior Vice President and leader of the St. Louis organization growing the staff to more than 250 people. Dr. Smoller earned a doctorate degree in Molecular Biology and a bachelor's degree in Biology from Emory University in Atlanta, Georgia. He completed a postdoctoral fellowship from Washington University in the Drosophila Genome project and a postdoctoral fellowship at Monsanto Corporation.

Listen to an interview with Dave about ZFNs